Paul N. Durrington

Manchester, ENG M139NT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications

Antioxidant Role of High-Density Lipoprotein.

Antioxidant Role of High-Density Lipoprotein.

Journal: Antioxidants (Basel, Switzerland)
Published: January 21, 2026

Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United Kingdom.

Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United Kingdom.

Journal: Genetics in medicine open
Published: February 14, 2025

How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport.

How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport.

Journal: Antioxidants (Basel, Switzerland)
Published: February 13, 2025

Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry.

Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 05, 2024

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): A retrospective cohort study of individuals with FH in UK primary care and the UK Simon Broome register, linked with national hospital records.

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): A retrospective cohort study of individuals with FH in UK primary care and the UK Simon Broome register, linked with national hospital records.

Journal: Atherosclerosis
Published: September 04, 2024

Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis.

Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis.

Journal: Current opinion in lipidology
Published: June 18, 2024

Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia.

Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia.

Journal: Current opinion in lipidology
Published: June 06, 2024

Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia.

Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia.

Journal: Frontiers in cardiovascular medicine
Published: February 20, 2024

Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).

Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).

Journal: Atherosclerosis
Published: September 25, 2023

Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery.

Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery.

Journal: Current opinion in lipidology
Published: August 10, 2023

An update on the first recorded case of familial hypercholesterolaemia: The Charioteer of Delphi.

An update on the first recorded case of familial hypercholesterolaemia: The Charioteer of Delphi.

Journal: Journal of clinical lipidology
Published: May 02, 2023

Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.

Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.

Journal: Metabolites
Published: March 05, 2023
Showing 1-12 of 81

Last Updated: 09/26/2026